000			02157 a2200589 4500
005			20250515165732.0
264		0	_c20090608
008			200906s 0 0 eng d
022			_a1558-8238
024	7		_a10.1172/JCI38482 _2doi
040			_aNLM _beng _cNLM
100	1		_aBruns, Heiko
245	0	0	_aAnti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. _h[electronic resource]
260			_bThe Journal of clinical investigation _cMay 2009
300			_a1167-77 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xmetabolism
650	0	4	_aAntirheumatic Agents _xtherapeutic use
650	0	4	_aArthritis, Rheumatoid _xmetabolism
650	0	4	_aAutoimmune Diseases _xtherapy
650	0	4	_aBlood Cell Count
650	0	4	_aCD8-Positive T-Lymphocytes _xcytology
650	0	4	_aComplement System Proteins _ximmunology
650	0	4	_aCytotoxicity, Immunologic _ximmunology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunity, Cellular _ximmunology
650	0	4	_aImmunotherapy _xadverse effects
650	0	4	_aInfliximab
650	0	4	_aInterferon-gamma _xmetabolism
650	0	4	_aLeukocytes, Mononuclear _ximmunology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMonocytes _ximmunology
650	0	4	_aMycobacterium tuberculosis _ximmunology
650	0	4	_aPerforin
650	0	4	_aPore Forming Cytotoxic Proteins _xmetabolism
650	0	4	_aT-Lymphocyte Subsets _xcytology
650	0	4	_aTuberculosis _ximmunology
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
650	0	4	_aVesicular Transport Proteins _xmetabolism
700	1		_aMeinken, Christoph
700	1		_aSchauenberg, Philipp
700	1		_aHärter, Georg
700	1		_aKern, Peter
700	1		_aModlin, Robert L
700	1		_aAntoni, Christian
700	1		_aStenger, Steffen
773	0		_tThe Journal of clinical investigation _gvol. 119 _gno. 5 _gp. 1167-77
856	4	0	_uhttps://doi.org/10.1172/JCI38482 _zAvailable from publisher's website
999			_c18812303 _d18812303